术前脑膜瘤栓塞的安全性特征:比较栓塞剂与栓塞颈动脉系统的Meta分析
该Meta分析纳入1974至2024年间50项研究共3069例患者,比较液体与颗粒栓塞剂及颈内动脉分支栓塞的安全性。总体并发症率为3.2%(95%CI:2.4-4.0%),永久性神经功能缺损率仅1.2%(0.8-1.6%)。液体与颗粒栓塞剂的总体并发症率相当,但液体栓塞剂导致肿瘤水肿引起神经功能缺损的比率略高。
要点
- 术前脑膜瘤栓塞总体并发症率3.2%(95%CI:2.4-4.0%),永久性神经功能缺损率1.2%(0.8-1.6%)。
- 液体与颗粒栓塞剂总体并发症率相当(P=0.28),但液体栓塞剂肿瘤水肿致神经功能缺损率略高(P=0.041)。
- 颈内动脉分支栓塞并发症率5.2%(1.1-9.2%)与颈外动脉栓塞2.5%(1.8-3.2%)相当(P=0.20)。
核心结论
- 术前栓塞是脑膜瘤切除术的安全辅助手段,液体与颗粒栓塞剂的并发症率均较低。
- 在特定病例中,颈内动脉分支栓塞与颈外动脉分支栓塞同样安全。
研究设计与样本
- 系统检索PubMed、Embase和Scopus数据库1974年至2024年间评估术前脑膜瘤栓塞结局的研究。
- Meta分析共纳入50项研究、3069例患者。
- 提取栓塞剂类型、栓塞供血动脉及并发症结局数据,采用基于合并率标准误计算的Z评分进行统计学比较。
主要发现
- 总体并发症率为3.2%(95%CI:2.4-4.0%),永久性神经功能缺损率为1.2%(0.8-1.6%)。
- 液体栓塞剂总体并发症率为4.1%(1.8-6.5%),颗粒栓塞剂为2.7%(1.7-3.6%),两组比较P=0.28。
- 液体栓塞剂肿瘤水肿导致神经功能缺损的比率为2.4%(0.6-4.2%),颗粒栓塞剂为0.5%(0.2-0.8%),两组比较P=0.041。
- 出血性并发症:液体栓塞剂2.3%,颗粒栓塞剂0.7%,P=0.087;缺血性并发症:液体栓塞剂1.6%,颗粒栓塞剂1.1%,P=0.53。
- 颈内动脉分支栓塞的合并并发症率为5.2%(1.1-9.2%),颈外动脉栓塞为2.5%(1.8-3.2%),两组比较P=0.20。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningiomas can be embolized to facilitate safe tumor resection. However, the procedure may be associated with complications that have not been well-characterized. We aimed to compare the safety of liquid versus particulate agents and to assess the safety of embolization using internal carotid artery (ICA) branches. METHODS: Studies evaluating outcomes of preoperative meningioma embolization from 1974 to 2024 were systematically searched on PubMed, Embase, and Scopus. Data on embolic agents used, feeder arteries embolized, and complication outcomes were extracted. Complication rates were statistically compared using Z-scores calculated from the standard errors of the pooled rates. RESULTS: The meta-analysis encompassed 3,069 patients from 50 studies. Embolization appears safe with an overall complication rate of 3.2% (95% CI: 2.4-4.0%) and a permanent neurological deficit rate of only 1.2% (0.8-1.6%). Overall complication rates were comparable between liquid (4.1%, 1.8-6.5%) and particulate agents (2.7%, 1.7-3.6%) (P = 0.28). The rate of tumor edema causing neurologic deficits was slightly higher for liquid agents (2.4%, 0.6-4.2%) compared to particulate agents (0.5%, 0.2-0.8%) (P = 0.041). No significant differences were observed in hemorrhagic (liquid 2.3%, particulate 0.7%; P = 0.087) or ischemic complications (liquid 1.6%, particulate 1.1%; P = 0.53). For the carotid systems embolized, the pooled complication rate for ICA branches embolization (5.2%, 1.1-9.2%) was comparable to the pooled complication rate of external carotid artery embolization (2.5%, 1.8-3.2%) (P = 0.20). CONCLUSIONS: Preoperative embolization is a safe adjunct for meningioma resection, with similarly low complication rates for liquid and particulate agents. Furthermore, embolization of ICA branches can be as safe as external carotid artery branches in select cases.
引用
- Alkhars H, Miyazaki NL, Obeidallah M, et al. Safety Profile of Preoperative Meningioma Embolization: A Meta-Analysis Comparing Embolic Agents and Carotid Systems Embolized. World Neurosurg. 2025. PMID: 39909106. doi:10.1016/j.wneu.2025.123733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。